Iht Wealth Management, LLC Clovis Oncology, Inc. Transaction History

Iht Wealth Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$5.69 - $9.69 $103,558 - $176,358	-18,200 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$3.77 - $11.0 $1,508 - $4,400	400 Added 2.25%	18,200 $116,000
Q4 2019 Feb 18, 2020	BUY	$3.0 - $16.43 $53,400 - $292,454	17,800 New	17,800 $186,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.